Is prophylactic ciprofloxacin effective in delaying biliary stent blockage?

Gastrointestinal Endoscopy

Volumn 52, Issue 2, 2000, Pages 175-182

  Leung, Joseph W ^a,b,c,d   Libby, Eric D ^a,b,c,d   Morck, Douglas W ^a,b,c,d   McKay, Sharon G ^a,b,c,d   Liu, Yan lei ^a,b,c,d   Lam, Kan ^a,b,c,d   Olson, Merle E ^a,b,c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA NORTHERN CALIFORNIA HEALTH CARE SYSTEM   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; POLYETHYLENE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIAL INFECTION; BACTERIUM CULTURE; BIOFILM; CAT; CONTROLLED STUDY; ENDOSCOPIC SURGERY; FEMALE; MALE; NONHUMAN; OBSTRUCTIVE JAUNDICE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; STENT; SURGICAL TECHNIQUE;

EID: 0033847218     PISSN: 00165107     EISSN: None     Source Type: Journal    
DOI: 10.1067/mge.2000.107716     Document Type: Article

References (41)

1. Endoscopic stenting for palliation of malignant biliary obstruction
2. Symptom relief and quality of life after stenting for malignant bile duct obstruction
3. Randomised trial of prevention of biliary stent occlusion by ursodeoxycholic acid plus norfloxacin
4. Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction
5. Prevention of biliary stent occlusion using cyclical antibiotics and ursodeoxycholic acid
6. A prospective, randomized, controlled trial of metal stents for malignant obstruction of the common bile duct
7. Endoscopic biliary endoprosthesis in the palliation of malignant obstruction of the distal common bile duct: A randomized trial
8. Randomised trial of endoscopic stenting versus surgical bypass in malignant low bile duct obstruction
9. Omitting side holes in biliary stents does not improve drainage of the obstructed biliary system: A prospective randomized trial
10. Investigation on the incrustation and obstruction of bile duct endoprostheses
11. Characterization of the content of occluded biliary endoprostheses
12. The role of bacteria in the blockage of biliary stents
13. Biliary stent blockage with bacterial biofilm
14. The clogged biliary endoprosthesis: Help on the way
15. A placebo-controlled study on the efficacy of aspirin and doxycycline in preventing clogging of biliary endoprostheses
16. A combination of Ciprofloxacin and Rowachol does not prevent biliary stent occlusion
17. Can Ciprofloxacin prevent blockage of polyethylene biliary stents?
18. Optimal timing for stent replacement in malignant biliary tract obstruction
19. Ascending infection of the biliary tract after surgical sphincterotomy and biliary stenting
20. Retrieval tail offsets advantage of proximal stent placement
21. Physicochemical and bacteriological analysis of the contents of occluded biliary endoprostheses
22. Pathogenesis of calcium bilirubinate gallstone: Role of E. coli, β-glucuronidase and coagulation by inorganic ions, polyelectrolytes and agitation
23. Clogging of biliary endoprostheses. A morphologic and bacteriologic study
24. Polyethylene stent blockage: A porcine model
25. Biliary bacteria: Significance and alteration after antibiotic therapy
26. Bacterial biofilm, brown pigment stone and blockage of biliary stents
27. Is there a synergistic effect between mixed bacterial infection in biofilm formation on biliary stents?
28. Tetracyclines and choramphenicol
29. Antibiotics, biliary sepsis and bile duct stones
30. Ciprofloxacin: Evaluation of its biliary excretion in man
31. The phamacokinetics of the biliary excretion of ciprofloxacin
32. Comparative pharmacokinetics of ofloxacin and ciprofloxacin
33. Endoscopic management of malignant biliary obstruction: Stents of 10 French gauge are preferable to stents of 8 French gauge
34. The bile acid composition of rabbit and cat gall-bladder bile
35. 3a-Hydroxylated bile acid profiles in clinically normal cats, cats with severe hepatic lipidosis, and cats with complete extrahepatic bile duct occlusion
36. Physiology and pathophysiology of bilirubin metabolism
37. Obstructive jaundice in a cat resulting from choledocholithiasis
38. Cholangitis, choledocholithiasis, and icterus in a cat
39. Adherence of resistant bacteria may account for failure of ciprofloxacin prophylaxis in stent blockage
40. Testing the susceptibility of bacteria in biofilm to antibacterial agents